Coriell Extends Its Scope

When New Jersey gave the Coriell Institute for Medical Research $5 million last year, it was the first time any state had funded an umbilical cord blood bank. But no other state has a research institute like Coriell, in Camden, across the Delaware River from Philadelphia. The nonprofit has, for nearly five decades, collected, stored, and cultured cells, providing them to almost every major research center worldwide. Courtesy of Coriell InstituteAn umbilical cord blood cassette used in storing t

Written byJennifer Fisher Wilson
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The new bank will store the umbilical cord blood gathered from the state's newborns. "Having a readily available source of stem cells that can be transplanted into unrelated recipients will be a major advance," said David P. Beck, the institute's president, at the time of the bank's establishment last November.

Cord blood research holds vast potential for therapeutic interventions. One day, it could even be possible to coax stem cells into taking on characteristics of other tissues by selected treatments and culture condition. The new bank will help Coriell with its ongoing research into cord blood, as well as provide a life-saving source of stem cells for bone marrow transplants.

Since its founding in 1953, Coriell has provided millions of cell samples to researchers, serving as the basis for groundbreaking discoveries on Huntington's disease, Alzheimer's disease, hypercholesterolemia, retinitis pigmentosa, and manic-depressive illness, among others, according to Coriell. The institute is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies